Phathom appoints Molly Henderson as CFO/Chief Business Officer; Guzzo to depart

Phathom Pharmaceuticals, Inc.

Molly Henderson, former Urogen Pharma CFO, becomes Chief Financial and Business Officer effective April 5, 2022.
Henderson's base salary $480,000; target bonus 45% of salary; receives options for 100k shares and 20k RSUs.
Anthony Guzzo, Chief Accounting Officer and acting principal financial officer, to depart around Aug 15, 2022.
Guzzo's departure not due to disagreement; vesting extended for certain PSVs and option exercise period to Dec 31, 2022.
Henderson replaces Guzzo as principal financial and accounting officer effective April 5, 2022.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Molly Henderson

Chief Financial and Business Officer

PHAT · Phathom Pharmaceuticals, Inc.

Effective: 2022-04-05
Filed: March 28, 2022, 7:59 PM ET

On March 22, 2022, Phathom Pharmaceuticals, Inc. (the “Company”) announced the appointment of Molly Henderson, 51, as its Chief Financial and Business Officer effective April 5, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Molly Henderson was appointed as Chief Financial and Business Officer at Phathom Pharmaceuticals, Inc..

Action: appointed
Role: Chief Financial and Business Officer

Exact text from the filing

On March 22, 2022, Phathom Pharmaceuticals, Inc. (the “Company”) announced the appointment of Molly Henderson, 51, as its Chief Financial and Business Officer effective April 5, 2022.

View on SEC.gov

Phathom Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-22-086616

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.